Why is this medication prescribed?

Elotuzumab is a medication used in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It is typically prescribed in combination with other medications, such as lenalidomide and dexamethasone, for patients who have received one to three prior treatments for their multiple myeloma.

Elotuzumab works by targeting a protein called SLAMF7, which is found on the surface of myeloma cells and natural killer cells of the immune system. By binding to SLAMF7, elotuzumab helps the immune system recognize and attack the myeloma cells, potentially slowing down the progression of the disease.

How should this medicine be used?

Elotuzumab is typically administered as an intravenous infusion, meaning it is injected directly into a vein over a period of time. Here’s a general overview of how elotuzumab injection is typically used:

• Administration Setting: Elotuzumab is usually administered in a healthcare facility, such as a hospital or clinic, under the supervision of a healthcare provider experienced in the use of cancer medications.
• Dosage: The dosage of elotuzumab can vary depending on factors such as the patient’s weight, overall health, and other medications being used. The exact dosage will be determined by a healthcare provider.
• Frequency: Elotuzumab is typically administered in combination with other medications, such as lenalidomide and dexamethasone, in treatment cycles. The frequency of administration and the duration of treatment cycles will be determined by a healthcare provider based on the specific treatment plan.
• Preparation: Before administration, the healthcare provider will prepare the elotuzumab solution according to the manufacturer’s instructions. This may involve diluting the medication with a compatible intravenous solution.
• Administration: The elotuzumab infusion is typically given slowly over a specified period of time, often ranging from one to two hours. The infusion rate may be adjusted based on the patient’s tolerance and any adverse reactions experienced.
• Monitoring: During and after the infusion, the patient will be closely monitored for any signs of allergic reactions or other adverse effects. Vital signs such as blood pressure, heart rate, and temperature may be monitored periodically.
• Follow-Up: After the infusion, patients will typically have follow-up appointments with their healthcare provider to assess the effectiveness of the treatment and monitor for any side effects. Additional treatment cycles may be scheduled as part of the overall treatment plan.

It’s important for patients to follow their healthcare provider’s instructions regarding the administration of elotuzumab and to report any unusual symptoms or side effects promptly. This helps ensure the best possible outcome and minimizes the risk of complications.

Other uses for this medicine

Elotuzumab injection is primarily used in the treatment of multiple myeloma, particularly in combination with other medications such as lenalidomide and dexamethasone. Currently, there are no other approved uses for elotuzumab beyond this specific indication.

What special precautions should I follow?

Regarding special precautions for elotuzumab injection, it’s essential for patients and healthcare providers to consider several factors:

• Allergic Reactions: Patients should be monitored closely for signs of allergic reactions during and after elotuzumab infusion. Symptoms of allergic reactions may include rash, itching, difficulty breathing, swelling of the face, lips, tongue, or throat. In case of a severe allergic reaction, treatment may be required, and infusion may need to be stopped.
• Infusion Reactions: Infusion reactions, such as fever, chills, nausea, headache, and low blood pressure, may occur during or shortly after elotuzumab infusion. Healthcare providers may administer medications to manage these symptoms or adjust the infusion rate as necessary.
• Infections: Elotuzumab treatment may increase the risk of infections, including bacterial, viral, or fungal infections. Patients should be monitored for signs of infection, and prompt treatment should be initiated if an infection develops.
• Pregnancy and Breastfeeding: Elotuzumab may harm an unborn baby, so it is not recommended during pregnancy. Women of childbearing potential should use effective contraception during treatment and for a certain period afterward. It’s not known whether elotuzumab passes into breast milk, so breastfeeding is not recommended during treatment and for a period afterward.
• Liver and Kidney Function: Elotuzumab may affect liver and kidney function. Patients with pre-existing liver or kidney conditions may require closer monitoring during treatment.
• Hematologic Effects: Elotuzumab treatment may lead to decreased blood cell counts, including white blood cells, red blood cells, and platelets. Regular blood tests may be necessary to monitor blood cell counts, and appropriate management strategies may be implemented if blood cell counts decrease significantly.
• Interactions with Other Medications: Patients should inform their healthcare providers about all medications, supplements, and herbal products they are taking before starting elotuzumab treatment. Some medications may interact with elotuzumab and affect its efficacy or increase the risk of adverse effects.

These precautions are essential to ensure the safe and effective use of elotuzumab in the treatment of multiple myeloma. Patients should discuss any concerns or questions about elotuzumab treatment with their healthcare providers.

What special dietary instructions should I follow?

Regarding special dietary instructions for Elotuzumab Injection, there are no specific dietary restrictions associated with its use. However, maintaining a balanced and nutritious diet can support overall health and may help manage potential side effects of treatment.

What should I do if I forget a dose?

If you forget a dose of Elotuzumab Injection, contact your healthcare provider as soon as possible to discuss the best course of action. Missing a dose may affect the effectiveness of the treatment, so it’s important to follow your prescribed treatment schedule as closely as possible. Your healthcare provider may provide guidance on whether the missed dose needs to be rescheduled or if any additional steps are necessary.

What side effects can this medication cause?

Elotuzumab injection, like any medication, can cause side effects. Some common side effects of elotuzumab may include:

• Infusion Reactions: Fever, chills, nausea, headache, flushing, and low blood pressure are common infusion-related reactions that may occur during or shortly after the infusion of elotuzumab. These reactions are typically mild to moderate in severity and can usually be managed with medications or adjustments to the infusion rate.
• Fatigue: Feeling tired or weak is a common side effect of elotuzumab treatment. Fatigue may vary in severity and can affect daily activities.
• Diarrhea: Some patients may experience diarrhea as a side effect of elotuzumab treatment. It’s important to stay hydrated and notify your healthcare provider if diarrhea is severe or persistent.
• Fever: Fever may occur as a side effect of elotuzumab treatment. Contact your healthcare provider if you develop a fever, especially if it is accompanied by other symptoms.
• Upper Respiratory Tract Infections: Infections of the upper respiratory tract, such as the common cold or sinus infections, may occur more frequently in patients receiving elotuzumab.
• Peripheral Edema: Swelling of the hands, feet, or ankles (peripheral edema) may occur as a side effect of elotuzumab treatment. Elevating the affected limbs and wearing compression stockings may help alleviate symptoms.
• Constipation: Some patients may experience constipation as a side effect of elotuzumab treatment. Drinking plenty of fluids, eating a high-fiber diet, and staying physically active may help prevent or relieve constipation.
• Decreased Blood Cell Counts: Elotuzumab treatment may lead to decreased counts of white blood cells, red blood cells, and platelets, which can increase the risk of infection, anemia, and bleeding. Regular blood tests will be conducted to monitor blood cell counts during treatment.

It’s important to note that not all patients will experience these side effects, and the severity and frequency of side effects can vary from person to person. Additionally, there may be other side effects not listed here. If you experience any concerning or persistent side effects while receiving elotuzumab treatment, be sure to notify your healthcare provider for further evaluation and management.

What should I know about storage and disposal of this medication?

Storage and disposal of Elotuzumab Injection:

• Storage: Elotuzumab injection should be stored in the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F). Do not freeze. Protect the medication from light. Keep it in its original carton until ready for use to protect it from light.
• Handling: Healthcare providers should follow appropriate procedures for handling and disposal of chemotherapy drugs to minimize the risk of exposure. Wear gloves when handling the medication to avoid direct contact with the skin or mucous membranes. If the medication comes into contact with the skin or mucous membranes, wash the area thoroughly with soap and water.
• Disposal: Unused or expired Elotuzumab Injection should be disposed of properly according to local regulations or guidelines for the disposal of hazardous waste. Do not dispose of medication in household trash or flush it down the toilet unless specifically instructed to do so.

In case of emergency/overdose

In case of emergency or overdose of Elotuzumab Injection:

• Symptoms: If you suspect an overdose or experience severe adverse reactions such as severe infusion reactions, allergic reactions, or other serious side effects, seek immediate medical attention.
• Treatment: Emergency medical treatment may be necessary depending on the severity of the overdose or adverse reaction. Treatment may include supportive care to manage symptoms and medications to counteract any adverse effects.

What other information should I know?

• Monitoring: Regular monitoring by your healthcare provider is essential during Elotuzumab Injection treatment to assess treatment response, monitor for side effects, and adjust treatment as needed.
• Follow-Up: Attend all scheduled appointments with your healthcare provider for monitoring and follow-up during and after Elotuzumab Injection treatment.
• Contraindications: Inform your healthcare provider of any pre-existing medical conditions, allergies, or medications you are taking before starting Elotuzumab Injection treatment.
• Pregnancy and Breastfeeding: Avoid becoming pregnant or breastfeeding while receiving Elotuzumab Injection, as it may harm the unborn baby or pass into breast milk.
• Inform Healthcare Providers: Make sure to inform all healthcare providers involved in your care that you are receiving Elotuzumab Injection, as it may interact with other medications or treatments.
• Patient Education: Educate yourself about the potential side effects, precautions, and proper administration of Elotuzumab Injection to ensure safe and effective treatment. Ask your healthcare provider any questions or concerns you may have about your treatment.